Structural brain changes in first episode Schizophrenia compared with Fronto-Temporal Lobar Degeneration: a meta-analysis

BMC Psychiatry

Volumn 12, Issue , 2012, Pages

  Olabi, Bayanne ^a   Ellison Wright, Ian ^b   Bullmore, Ed ^c,d   Lawrie, Stephen M ^a  

^a ROYAL EDINBURGH HOSPITAL   (United Kingdom)

^b AVON AND WILTSHIRE MENTAL HEALTH PARTNERSHIP NHS TRUST   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d CAMBRIDGESHIRE AND PETERBOROUGH NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Brain mapping; Brain pathology; Computer Assisted methods; FTLD pathology; Humans; Imaging processing; Magnetic resonance imaging methods; Meta analysis; Schizophrenia pathology

Indexed keywords

ARTICLE; BRAIN MAPPING; CAUDATE NUCLEUS; COMPARATIVE STUDY; FRONTOTEMPORAL DEMENTIA; GRAY MATTER; HUMAN; INSULA; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; SCHIZOPHRENIA; SYSTEMATIC REVIEW; UNCUS; VOXEL BASED MORPHOMETRY; BRAIN REGION; NEUROANATOMY;

BRAIN; BRAIN MAPPING; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; SCHIZOPHRENIA;

EID: 84864754663     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-12-104     Document Type: Article

References (113)

1. Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry 2008, 165(8):1015-23. 10.1176/appi.ajp.2008.07101562, 2873788, 18381902.
2. Keshavan MS, Tandon R, Boutros NN, Nasrallah HA. Schizophrenia, "just the facts": what we know in 2008 Part 3: neurobiology. Schizophr Res 2008, 106(2-3):89-107.
3. Goghari VM, Sponheim SR, MacDonald AW. The functional neuroanatomy of symptom dimensions in schizophrenia: a qualitative and quantitative review of a persistent question. Neurosci Biobehav Rev 2010, 34(3):468-86. 10.1016/j.neubiorev.2009.09.004, 2813961, 19772872.
4. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998, 51:1546-54. 10.1212/WNL.51.6.1546, 9855500.
5. Mohandas E, Rajmohan V. Frontotemporal dementia: An updated overview. Indian J Psychiatry 2009, 51(Suppl 1):S65-9. 3038533, 21416021.
6. Taniguchi S, McDonagh AM, Pickering-Brown SM, Umeda Y, Iwatsubo T, Hasegawa M, Mann DM. The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein. Neuropath Appl Neurobiol 2004, 30:1-18.
7. Neary D, Snowden J, Mann D. Frontotemporal dementia. Lancet Neurol 2005, 4:771-80.
8. Momeni P, Wickremaratchi MM, Bell J, Arnold R, Beer R, Hardy J, Revesz T, Neal JW, Morris HR. Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia. Clin Neurol Neurosurg 2010, 112(10):917-20. 10.1016/j.clineuro.2010.07.015, 20708332.
9. Velakoulis D, Walterfang M, Mocellin R, Pantelis C, McLean C. Frontotemporal dementia presenting as schizophrenia-like psychosis in young people: clinicopathological series and review of cases. Br J Psychiatry 2009, 194(4):298-305. 10.1192/bjp.bp.108.057034, 19336778.
10. Pantelis C, Barnes TR, Nelson HE, Tanner S, Weatherley L, Owen AM, Robbins TW. Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain 1997, 120(Pt 10):1823-43.
11. Shamay-Tsoory SG, Aharon-Peretz J, Levkovitz Y. The neuroanatomical basis of affective mentalizing in schizophrenia: comparison of patients with schizophrenia and patients with localized prefrontal lesions. Schizophr Res 2007, 90(1-3):274-83.
12. Lawrie SM, Abukmeil SS. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry 1998, 172:110-20. 10.1192/bjp.172.2.110, 9519062.
13. Velakoulis D, Wood SJ, Wong MT, McGorry PD, Yung A, Phillips L, Smith D, Brewer W, Proffitt T, Desmond P, Pantelis C. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry 2006, 63(2):139-49. 10.1001/archpsyc.63.2.139, 16461856.
14. Kaufer DI, Miller BL, Itti L, Fairbanks LA, Li J, Fishman J, Kushi J, Cummings JL. Midline cerebral morphometry distinguishes frontotemporal dementia and Alzheimer's disease. Neurology 1997, 48(4):978-85. 10.1212/WNL.48.4.978, 9109887.
15. Walterfang M, Wood AG, Reutens DC, Wood SJ, Chen J, Velakoulis D, McGorry PD, Pantelis C. Morphology of the corpus callosum at different stages of schizophrenia: cross-sectional study in first episode and chronic illness. Br J Psychiatry 2008, 192(6):429-34. 10.1192/bjp.bp.107.041251, 18515892.
16. Laakso MP, Frisoni GB, Kononen M, Mikkonen M, Beltramello A, Geroldi C, Bianchetti A, Trabucchi M, Soininen H, Aronen HJ. Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer's disease: a morphometric MRI study. Biol Psychiatry 2000, 47:1056-63. 10.1016/S0006-3223(99)00306-6, 10862805.
17. Velakoulis D, Stuart GW, Wood SJ, Smith DJ, Brewer WJ, Desmond P, Singh B, Copolov D, Pantelis C. Selective bilateral hippocampal volume loss in chronic schizophrenia. Biol Psychiatry 2001, 50:531-9. 10.1016/S0006-3223(01)01121-0, 11600106.
18. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001, 58:1803-9. 10.1001/archneur.58.11.1803, 11708987.
19. Velakoulis D, Pantelis C. What have we learned from functional imaging studies in schizophrenia? The role of frontal, striatal and temporal areas. Aust N Z J Psychiatry 1996, 30:195-209. 10.3109/00048679609076095, 8811262.
20. Schoder D, Hannequin D, Martinaud O, Opolczynski G, Guyant-Maréchal L, Le Ber I, Campion D. Morbid risk for schizophrenia in first-degree relatives of people with frontotemporal dementia. Br J Psychiatry 2010, 197:28-35. 10.1192/bjp.bp.109.068981, 20592430.
21. Pickering-Brown SM. The complex aetiology of frontotemporal lobar degeneration. Exp Neurol 2007, 206(1):1-10. 10.1016/j.expneurol.2007.03.017, 17509568.
22. Aswathy PM, Jairani PS, Mathuranath PS. Genetics of frontotemporal lobar degeneration. Ann Indian Acad Neurol 2010, 13(Suppl 2):S55-62. 3039162, 21369419.
23. Goghari VM, Lang DJ, Khorram B, Götz J, Vandorpe RA, Smith GN, Kopala LC, Barr AM, Honer WG. Anterior internal capsule volumes increase in patients with schizophrenia switched from typicalantipsychotics to olanzapine. J Psychopharmacol 2011, 25(5):621-9. 10.1177/0269881110363314, 20360156.
24. Molina V, Reig S, Sanz J, Palomo T, Benito C, Sánchez J, Pascau J, Desco M. Changes in cortical volume with olanzapine in chronic schizophrenia. Pharmacopsychiatry 2007, 40(4):135-9. 10.1055/s-2007-981479, 17694474.
25. Eickhoff SB, Laird AR, Grefkes C, Wang LE, Zilles K, Fox PT. Coordinate-based activation likelihood estimation meta-analysis of neuroimaging data: A random-effects approach based on empirical estimates of spatial uncertainty. Hum Brain Mapp 2009, 30:2907-2926. 10.1002/hbm.20718, 2872071, 19172646.
26. Morris SE, Cuthbert BN. Research Domain Criteria: cognitive systems, neural circuits and dimensions of behaviour. Dialogues Clin Neurosci 2012, 14(1):29-37. 3341647, 22577302.
27. Takayanagi Y, Takahashi T, Orikabe L, Mozue Y, Kawasaki Y, Nakamura K, Sato Y, Itokawa M, Yamasue H, Kasai K, Kurachi M, Okazaki Y, Suzuki M. Classification of first-episode schizophrenia patients and healthy subjects by automated MRI measures of regional brain volume and cortical thickness. PLoS One 2011, 6(6):e21047. 10.1371/journal.pone.0021047, 3119676, 21712987.
28. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009, 339:b2700. 10.1136/bmj.b2700, 2714672, 19622552.
29. Laird AR, Fox PM, Price CJ, Glahn DC, Uecker AM, Lancaster JL, Turkeltaub PE, Kochunov P, Fox PT. ALE meta-analysis: controlling the false discovery rate and performing statistical contrasts. Hum Brain Mapp 2005, 25:155-164. 10.1002/hbm.20136, 15846811.
30. Verhoeven KJF, Simonsen KL, McIntyre LM. Implementing false discovery rate control: increasing your power. Oikos 2005, 108:643-647.
31. Ellison-Wright I, Ellison-Wright Z, Bullmore E. Structural brain change in Attention Deficit Hyperactivity Disorder identified by meta-analysis. BMC Psychiatry 2008, 8:51. 10.1186/1471-244X-8-51, 2453122, 18590567.
32. Bergé D, Carmona S, Rovira M, Bulbena A, Salgado P, Vilarroya O. Gray matter volume deficits and correlation with insight and negative symptoms in first-psychotic-episode subjects. Acta Psychiatr Scand 2011, 123(6):431-9. 10.1111/j.1600-0447.2010.01635.x, 21054282.
33. Chua SE, Cheung C, Cheung V, Tsang JT, Chen EY, Wong JC, Cheung JP, Yip L, Tai KS, Suckling J, McAlonan GM. Cerebral grey, white matter and CSF in never-medicated, first-episode schizophrenia. Schizophr Res 2007, 89:12-21. 10.1016/j.schres.2006.09.009, 17098398.
34. Douaud G, Smith S, Jenkinson M, Behrens T, Johansen-Berg H, Vickers J, James S, Voets N, Watkins K, Matthews PM, James A. Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. Brain 2007, 130:2375-86. 10.1093/brain/awm184, 17698497.
35. Ebdrup BH, Glenthøj B, Rasmussen H, Aggernaes B, Langkilde AR, Paulson OB, Lublin H, Skimminge A, Baaré W. Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia. J Psychiatry Neurosci 2010, 35(2):95-104. 10.1503/jpn.090049, 2834791, 20184807.
36. Jayakumar PN, Venkatasubramanian G, Gangadhar BN, Janakiramaiah N, Keshavan MS. Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naive schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:587-91. 10.1016/j.pnpbp.2005.01.020, 15866362.
37. Job DE, Whalley HC, McConnell S, Glabus M, Johnstone EC, Lawrie SM. Structural gray matter differences between first-episode schizophrenics and normal controls using voxel-based morphometry. Neuroimage 2002, 17:880-9. 10.1006/nimg.2002.1180, 12377162.
38. Kasparek T, Prikryl R, Mikl M, Schwarz D, Ceskova E, Krupa P. Prefrontal but not temporal grey matter changes in males with first-episode schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:151-7. 10.1016/j.pnpbp.2006.08.011, 17011096.
39. Kubicki M, Shenton ME, Salisbury DF, Hirayasu Y, Kasai K, Kikinis R, Jolesz FA, McCarley RW. Voxel-based morphometric analysis of gray matter in first episode schizophrenia. Neuroimage 2002, 17(4):1711-9. 10.1006/nimg.2002.1296, 2845166, 12498745.
40. Lui S, Deng W, Huang X, Jiang L, Ma X, Chen H, Zhang T, Li X, Li D, Zou L, Tang H, Zhou XJ, Mechelli A, Collier DA, Sweeney JA, Li T, Gong Q. Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study. Am J Psychiatry 2009, 166(2):196-205. 10.1176/appi.ajp.2008.08020183, 18981063.
41. Meda SA, Giuliani NR, Calhoun VD, Jagannathan K, Schretlen DJ, Pulver A, Cascella N, Keshavan M, Kates W, Buchanan R, Sharma T, Pearlson GD. A large scale (N = 400) investigation of gray matter differences in schizophrenia using optimized voxel-based morphometry. Schizophr Res 2008, 101(1-3):95-105. 2504740, 18378428.
42. Molina V, Sanz J, Villa R, Pérez J, González D, Sarramea F, Ballesteros A, Galindo G, Hernández JA. Voxel-based morphometry comparison between first episodes of psychosis with and without evolution to schizophrenia. Psychiatry Res 2010, 181(3):204-10. 10.1016/j.pscychresns.2009.09.003, 20153145.
43. Price G, Cercignani M, Chu EM, Barnes TR, Barker GJ, Joyce EM, Ron MA. Brain pathology in first-episode psychosis: magnetization transfer imaging provides additional information to MRI measurements of volume loss. Neuroimage 2010, 49(1):185-92. 10.1016/j.neuroimage.2009.07.037, 2806943, 19632338.
44. Salgado-Pineda P, Baeza I, Perez-Gomez M, Vendrell P, Junque C, Bargallo N, Bernardo M. Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients. Neuroimage 2003, 19:365-75. 10.1016/S1053-8119(03)00094-6, 12814586.
45. Schaufelberger MS, Duran FL, Lappin JM, Scazufca M, Amaro E, Leite CC, De Castro CC, Murray RM, McGuire PK, Menezes PR, Busatto GF. Grey matter abnormalities in Brazilians with first-episode psychosis. Br J Psychiatry Suppl 2007, 51:s117-22.
46. Venkatasubramanian G. Neuroanatomical correlates of psychopathology in antipsychotic-naïve schizophrenia. Indian J Psychiatry 2010, 52(1):28-36. 10.4103/0019-5545.58892, 2824977, 20174515.
47. Whitford TJ, Farrow TF, Gomes L, Brennan J, Harris AW, Williams LM. Grey matter deficits and symptom profile in first episode schizophrenia. Psychiatry Res 2005, 139:229-38. 10.1016/j.pscychresns.2005.05.010, 16055311.
48. Witthaus H, Kaufmann C, Bohner G, Ozgürdal S, Gudlowski Y, Gallinat J, Ruhrmann S, Brüne M, Heinz A, Klingebiel R, Juckel G. Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls. Psychiatry Res 2009, 173(3):163-9. 10.1016/j.pscychresns.2008.08.002, 19616415.
49. Yoshihara Y, Sugihara G, Matsumoto H, Suckling J, Nishimura K, Toyoda T, Isoda H, Tsuchiya KJ, Takebayashi K, Suzuki K, Sakahara H, Nakamura K, Mori N, Takei N. Voxel-based structural magnetic resonance imaging (MRI) study of patients with early onset schizophrenia. Ann Gen Psychiatry 2008, 7:25. 10.1186/1744-859X-7-25, 2628340, 19102744.
50. Adlam AL, Patterson K, Rogers TT, Nestor PJ, Salmond CH, Acosta-Cabronero J, Hodges JR. Semantic dementia and fluent primary progressive aphasia: two sides of the same coin?. Brain 2006, 129(Pt 11):3066-80.
51. Boccardi M, Sabattoli F, Laakso MP, Testa C, Rossi R, Beltramello A, Soininen H, Frisoni GB. Frontotemporal dementia as a neural system disease. Neurobiol Aging 2005, 26(1):37-44. 10.1016/j.neurobiolaging.2004.02.019, 15585344.
52. Boxer AL, Rankin KP, Miller BL, Schuff N, Weiner M, Gorno-Tempini ML, Rosen HJ. Cinguloparietal atrophy distinguishes Alzheimer disease from semantic dementia. Arch Neurol 2003, 60(7):949-56. 10.1001/archneur.60.7.949, 12873851.
53. Chang JL, Lomen-Hoerth C, Murphy J, Henry RG, Kramer JH, Miller BL, Gorno-Tempini ML. A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology 2005, 65(1):75-80. 10.1212/01.wnl.0000167602.38643.29, 16009889.
54. Desgranges B, Matuszewski V, Piolino P, Chételat G, Mézenge F, Landeau B, de la Sayette V, Belliard S, Eustache F. Anatomical and functional alterations in semantic dementia: a voxel-based MRI and PET study. Neurobiol Aging 2007, 28(12):1904-13. 10.1016/j.neurobiolaging.2006.08.006, 16979268.
55. Gee J, Ding L, Xie Z, Lin M, DeVita C, Grossman M. Alzheimer's disease and frontotemporal dementia exhibit distinct atrophy-behavior correlates: a computer-assisted imaging study. Acad Radiol 2003, 10(12):1392-401. 10.1016/S1076-6332(03)00543-9, 14697007.
56. Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM, Phengrasamy L, Rosen HJ, Johnson JK, Weiner MW, Miller BL. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 2004, 55(3):335-46. 10.1002/ana.10825, 2362399, 14991811.
57. Grossman M, McMillan C, Moore P, Ding L, Glosser G, Work M, Gee J. What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration. Brain 2004, 127(Pt 3):628-49.
58. Kanda T, Ishii K, Uemura T, Miyamoto N, Yoshikawa T, Kono AK, Mori E. Comparison of grey matter and metabolic reductions in frontotemporal dementia using FDG-PET and voxel-based morphometric MR studies. Eur J Nucl Med Mol Imaging 2008, 35(12):2227-34. 10.1007/s00259-008-0871-5, 18661129.
59. Kim EJ, Rabinovici GD, Seeley WW, Halabi C, Shu H, Weiner MW, DeArmond SJ, Trojanowski JQ, Gorno-Tempini ML, Miller BL, Rosen HJ. Patterns of MRI atrophy in tau positive and ubiquitin positive frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry 2007, 78(12):1375-8. 10.1136/jnnp.2006.114231, 2095621,2095621, 17615169.
60. Libon DJ, McMillan C, Gunawardena D, Powers C, Massimo L, Khan A, Morgan B, Farag C, Richmond L, Weinstein J, Moore P, Coslett HB, Chatterjee A, Aguirre G, Grossman M. Neurocognitive contributions to verbal fluency deficits in frontotemporal lobar degeneration. Neurology 2009, 73(7):535-42. 10.1212/WNL.0b013e3181b2a4f5, 2730797, 19687454.
61. Massimo L, Powers C, Moore P, Vesely L, Avants B, Gee J, Libon DJ, Grossman M. Neuroanatomy of apathy and disinhibition in frontotemporal lobar degeneration. Dement Geriatr Cogn Disord 2009, 27(1):96-104. 10.1159/000194658, 2820577, 19158440.
62. Mummery CJ, Patterson K, Price CJ, Ashburner J, Frackowiak RS, Hodges JR. A voxel-based morphometry study of semantic dementia: relationship between temporal lobe atrophy and semantic memory. Ann Neurol 2000, 47(1):36-45. 10.1002/1531-8249(200001)47:1<36::AID-ANA8>3.0.CO;2-L, 10632099.
63. Nestor PJ, Graham NL, Fryer TD, Williams GB, Patterson K, Hodges JR. Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula. Brain 2003, 126(Pt 11):2406-18.
64. Pardini M, Huey ED, Cavanagh AL, Grafman J. Olfactory function in corticobasal syndrome and frontotemporal dementia. Arch Neurol 2009, 66(1):92-6. 10.1001/archneurol.2008.521, 2987736, 19139305.
65. Pereira JM, Williams GB, Acosta-Cabronero J, Pengas G, Spillantini MG, Xuereb JH, Hodges JR, Nestor PJ. Atrophy patterns in histologic vs clinical groupings of frontotemporal lobar degeneration. Neurology 2009, 72(19):1653-60. 10.1212/WNL.0b013e3181a55fa2, 2827263, 19433738.
66. Rabinovici GD, Seeley WW, Kim EJ, Gorno-Tempini ML, Rascovsky K, Pagliaro TA, Allison SC, Halabi C, Kramer JH, Johnson JK, Weiner MW, Forman MS, Trojanowski JQ, Dearmond SJ, Miller BL, Rosen HJ. Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen 2007, 22(6):474-88. 2443731, 18166607.
67. Rosen HJ, Gorno-Tempini ML, Goldman WP, Perry RJ, Schuff N, Weiner M, Feiwell R, Kramer JH, Miller BL. Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology 2002, 58(2):198-208. 10.1212/WNL.58.2.198, 11805245.
68. Seeley WW, Crawford R, Rascovsky K, Kramer JH, Weiner M, Miller BL, Gorno-Tempini ML. Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol 2008, 65(2):249-55. 10.1001/archneurol.2007.38, 2544627, 18268196.
69. Williams GB, Nestor PJ, Hodges JR. Neural correlates of semantic and behavioural deficits in frontotemporal dementia. Neuroimage 2005, 24(4):1042-51. 10.1016/j.neuroimage.2004.10.023, 15670681.
70. Bora E, Fornito A, Yücel M, Pantelis C. The effects of gender on grey matter abnormalities in major psychoses: a comparative voxelwise meta-analysis of schizophreniaand bipolar disorder. Psychol Med 2011, 11:1-13.
71. Yu K, Cheung C, Leung M, Li Q, Chua S, McAlonan G. Are Bipolar Disorder and Schizophrenia Neuroanatomically Distinct?. An Anatomical Likelihood Meta-analysis. Front Hum Neurosci 2010, 4:189.
72. Ellison-Wright I, Bullmore E. Anatomy of bipolar disorder and schizophrenia: a meta-analysis. Schizophr Res 2010, 117(1):1-12. 10.1016/j.schres.2009.12.022, 20071149.
73. Sundram F, Cannon M, Doherty CP, Barker GJ, Fitzsimons M, Delanty N, Cotter D. Neuroanatomical correlates of psychosis in temporal lobe epilepsy: voxel-based morphometry study. Br J Psychiatry 2010, 197(6):482-92. 10.1192/bjp.bp.110.080218, 21119155.
74. Cascella NG, Schretlen DJ, Sawa A. Schizophrenia and epilepsy: is there a shared susceptibility?. Neurosci Res 2009, 63(4):227-35. 10.1016/j.neures.2009.01.002, 2768382, 19367784.
75. Labate A, Cerasa A, Gambardella A, Aguglia U, Quattrone A. Hippocampal and thalamic atrophy in mild temporal lobe epilepsy: a VBM study. Neurology 2008, 71(14):1094-101. 10.1212/01.wnl.0000326898.05099.04, 18824674.
76. Cheung C, Yu K, Fung G, Leung M, Wong C, Li Q, Sham P, Chua S, McAlonan G. Autistic disorders and schizophrenia: related or remote? An anatomical likelihood estimation. PLoS One 2010, 5(8):e12233. 10.1371/journal.pone.0012233, 2923607, 20805880.
77. Burbach JP, van der Zwaag B. Contact in the genetics of autism and schizophrenia. Trends Neurosci 2009, 32:69-72. 10.1016/j.tins.2008.11.002, 19135727.
78. Goodman AB. A family history study of schizophrenia spectrum disorders suggests new candidate genes in schizophrenia and autism. Psychiatr Q 1994, 65:287-297. 10.1007/BF02354305, 7831415.
79. McGrath J, Eyles D, Mowry B, Yolken R, Buka S. Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera. Schizophr Res 2003, 63:73-78. 10.1016/S0920-9964(02)00435-8, 12892860.
80. Cannell JJ. Autism and vitamin D. Med Hypotheses 2008, 70:750-759. 10.1016/j.mehy.2007.08.016, 17920208.
81. Brown AS. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull 2006, 32:200-202. 10.1093/schbul/sbj052, 2632220, 16469941.
82. Chess S. Autism in children with congenital rubella. J Autism Child Schizophr 1971, 1:33-47. 10.1007/BF01537741, 5172438.
83. Sommer I, Ramsey N, Kahn R, Aleman A, Bouma A. Handedness, language lateralisation and anatomical asymmetry in schizophrenia: meta-analysis. Br J Psychiatry 2001, 178:344-351. 10.1192/bjp.178.4.344, 11282814.
84. Konick LC, Friedman L. Meta-analysis of thalamic size in schizophrenia. Biol Psychiatry 2001, 49:28-38. 10.1016/S0006-3223(00)00974-4, 11163777.
85. Wright IC, Rabe-Hesketh S, Woodruff PWR, David AS, Murray RM, Bullmore ET. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 2000, 157:16-25.
86. Zakzanis KK, Poulin P, Hansen KT, Jolic D. Searching the schizophrenic brain for temporal lobe deficits: a systematic review and meta-analysis. Psychol Med 2000, 30:491-504. 10.1017/S0033291799002172, 10883706.
87. Nelson MD, Saykin AJ, Flashman LA, Riordan HJ. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry 1998, 55:433-440. 10.1001/archpsyc.55.5.433, 9596046.
88. Chance SA, Esiri MM, Crow TJ. Amygdala volume in schizophrenia: post-mortem study and review of magnetic resonance imaging findings. Br J Psychiatry 2002, 180:331-338. 10.1192/bjp.180.4.331, 11925356.
89. Vita A, De Peri L. Hippocampal and amygdala volume reductions in first-episode schizophrenia. Br J Psychiatry 2007, 190:271.
90. Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr Res 2001, 49:1-52.
91. Ananth H, Popescu I, Critchley HD, Good CD, Frackowiak RSJ, Dolan RJ. Cortical and subcortical gray matter abnormalities in schizophrenia determined through structural magnetic resonance imaging with optimized volumetric voxel-based morphometry. Am J Psychiatry 2002, 159:1497-1505. 10.1176/appi.ajp.159.9.1497, 12202269.
92. Salgado-Pineda P, Baeza I, Pérez-Gómez M, Vendrell P, Junqué C, Bargalló N, Bernardo M. Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients. Neuroimage 2003, 19:365-375. 10.1016/S1053-8119(03)00094-6, 12814586.
93. Leung M, Cheung C, Yu K, Yip B, Sham P, Li Q, Chua S, McAlonan G. Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting. Schizophr Bull 2011, 37(1):199-211.
94. Chan RC, Di X, McAlonan GM, Gong QY. Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression. Schizophr Bull 2011, 37(1):177-88. 10.1093/schbul/sbp073, 3004195, 19633214.
95. Schroeter ML, Raczka K, Neumann J, YvesVon Cramon D. Towards a nosology for frontotemporal lobar degenerations - a meta-analysis involving 267 subjects. Neuroimage 2007, 36(3):497-510. 10.1016/j.neuroimage.2007.03.024, 17478101.
96. Lund T, Groups M. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994, 57:416-418. 1072868, 8163988.
97. Middleton FA, Strick PL. Basal ganglia output and cognition: evidence from anatomical, behavioral, and clinical studies. Brain Cogn 2000, 42:183-200. 10.1006/brcg.1999.1099, 10744919.
98. Middleton FA, Strick PL. Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res Rev 2000, 31:236-250. 10.1016/S0165-0173(99)00040-5, 10719151.
99. Delong MR, Wichman T. Circuits and circuit disorders of the basal ganglia. Arch Neurol 2007, 64(1):20-24. 10.1001/archneur.64.1.20, 17210805.
100. Gao WJ, Wang Y, Goldman-Rakic PS. Dopamine modulation of perisomatic and peridendritic inhibition in prefrontal cortex. J Neurosci 2003, 23:1622-1630.
101. Cassady SL, Adami H, Moran M, Kunkel R, Thaker GK. Spontaneous dyskinesia in subjects with schizophrenia spectrum personality. Am J Psychiatry 1998, 155(1):70-5.
102. Fish B, Marcus J, Hans SL, Auerbach JG, Purdue S. Infants at risk for schizophrenia: Sequelae of a genetic neurointegrative defect. Arch Gen Psychiatry 1992, 49:221-235. 10.1001/archpsyc.1992.01820030053007, 1373598.
103. Robbins TW. The case of frontostriatal dysfunction in schizophrenia. Schizophr Bull 1990, 16(3):391-402.
104. Garey LJ. Brodmann's Localisation in the Cerebral Cortex 1994, London: Smith-Gordon, 3484150, 23118852.
105. Mesulam MM. Principles of Behavioural and Cognitive Neurology 2000, New York: Oxford University Press.
106. Kiehl KA. A cognitive neuroscience perspective on psychopathy: evidence or paralimbic system dysfunction. Psychiatry Res 2006, 142(2-3):107-28. 2765815, 16712954.
107. Skaf CR, Yamada A, Garrido GE, Buchpiguel CA, Akamine S, Castro CC, Busatto GF. Psychotic symptoms in major depressive disorder are associated with reduced regional cerebral blood flow in the subgenual anterior cingulate cortex: a voxel-based single photon emission computed tomography (SPECT) study. J Affect Disord 2002, 68(2-3):295-305.
108. Rubia K. "Cool" inferior frontostriatal dysfunction in attention-deficit/hyperactivity disorder versus "hot" ventromedial orbitofrontal-limbic dysfunction in conduct disorder: a review. Biol Psychiatry 2011, 69(12):e69-87. 10.1016/j.biopsych.2010.09.023, 21094938.
109. Grahn JA, Parkinson JA, Owen AM. The role of the basal ganglia in learning and memory: neuropsychological studies. Behav Brain Res 2009, 199(1):53-60. 10.1016/j.bbr.2008.11.020, 19059285.
110. Grahn JA, Parkinson JA, Owen AM. The cognitive functions of the caudate nucleus. Prog Neurobiol 2008, 86(3):141-55. 10.1016/j.pneurobio.2008.09.004, 18824075.
111. Vemuri P, Wiste HJ, Weigand SD, Knopman DS, Trojanowski JQ, Shaw LM, Bernstein MA, Aisen PS, Weiner M, Petersen RC, Jack CR. Alzheimer's disease neuroimaging initiative: Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology 2010, 75(2):143-51. 10.1212/WNL.0b013e3181e7ca82, 2905929, 20625167.
112. Zalesky A, Fornito A, Bullmore ET. Network-based statistic: identifying differences in brain networks. Neuroimage 2010, 53(4):1197-207. 10.1016/j.neuroimage.2010.06.041, 20600983.
113. Tijms BM, Seriès P, Willshaw DJ, Lawrie SM. Similarity-based extraction of individual networks from gray matter MRI scans. Cereb Cortex 2012, 22(7):1530-41. 10.1093/cercor/bhr221, 21878484.